The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Biomarkers, 2010Prospective Validation of Risk Markers for the Development of Parkinson’s Disease
Promising Outcomes of Original Grant:
As Parkinson’s disease is diagnosed when already a number of neurons have degenerated the PRIPS cohort consisting of 1847 healthy subjects older than 50 years was... -
MJFF Research Grant, 2010Optimization of Optical Coherence Tomography as a Biomarker for Parkinson's Disease
Objective/Rationale:
Determine the thickness of the neural part of the eye, the retina in patients suffering from Parkinson Disease and in healthy, age matched subjects.Project Description:
Patients... -
MJFF Research Grant, 2010Making PSG Databases Available to Researchers
Objective/Rationale:
Information from clinical trials is not easily available to most researchers, especially if the trials are sponsored by industry. Making information from clinical trials more... -
Rapid Response Innovation Awards, 2010Increasing Endogenous Neurogenesis Using Neurosteroids: A Novel Therapeutic Strategy to Treat Parkinson's Disease
Objective/Rationale:
We will test a locally produced brain chemical that increases the generation of new neurons to replace the damaged neurons in Parkinson disease (PD). The production of this... -
Neurotrophic Factor Therapies for Parkinson's Disease, 2010CERE-120 Long-Term Subject Follow-Up
Outcomes of Original Grant:
Neurotrophic factors including neurturin (NTN) have been shown to effectively augment the function and prevent the death of dopaminergic nigrostriatal neurons in animal... -
Neurotrophic Factor Therapies for Parkinson's Disease, 2010Intermittent Bilateral Intraputamenal Treatment with GDNF
Objective/Rationale:
Glial cell-derived neurotrophic factor (GDNF) has been shown in various pre-clinical models of Parkinson's disease (PD) to restore damaged nerve cells, including dopamine...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.